Sort
16,300 grants matching “fatty liver disease”
Hepatocyte TMEM141 in Lipoprotein Metabolism
$744,453Yanqiao Zhang · University Of Arizona · R01 · FY2025 · HL
Caregivers as the Agent of Change for Childhood Obesity and Chronic Disease Risk Among Latino Families
$744,432Kerri N Boutelle · Children'S Hospital Of Los Angeles · P50 · FY2024 · MD
Adverse metabolic effects of dietary sugar _ Ad libitum vs energy-balanced diets
$743,385Peter J Havel · University Of California At Davis · R01 · FY2014 · HL
The Gut Microbiota and Graft versus Host Disease (GVHD)
$743,338David Neal Fredricks · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI
Food Prescriptions to Promote Affordable Diets that Meet RDAs Among Multi-Generational Latino Households
$743,228Deborah A Cohen · Children'S Hospital Of Los Angeles · P50 · FY2025 · MD
Biobehavioral Studies of Obesity, Weight loss and Recidivism
$743,056Ranganath Muniyappa · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Novel IL-23 inhibitor for the treatment of alcohol associated liver disease
$742,984Rohit Loomba · University Of California, San Diego · U01 · FY2023 · AA
Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease
$742,803Thorsten M Leucker · Johns Hopkins University · R01 · FY2024 · HL
Optimization and preclinical development of FAAH inhibitors for smoking cessation
$742,050Daniele Piomelli · University Of California-Irvine · DP1 · FY2014 · DA
Metabolic impact of fructose restriction in obese children
$741,779Jean-Marc Schwarz · Touro University Of California · R01 · FY2010 · DK
Methods for Genomic Analysis in Heterogeneous Tissues
$741,588Eran Halperin · University Of California Los Angeles · R01 · FY2019 · HG
Caregivers as the Agent of Change for Childhood Obesity and Chronic Disease Risk Among Latino Families
$741,527Kerri N Boutelle · Children'S Hospital Of Los Angeles · P50 · FY2023 · MD
Generating Exogenic Organs for Transplantation without the Use of Immunosuppression
$741,456Clifford J. Steer · University Of Minnesota · R01 · FY2025 · AI
Mechanisms for Arsenic-Induced Vascular Disease
$741,303Aaron Barchowsky · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · ES
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD
$741,152Scott B. Reeder · University Of Wisconsin-Madison · R01 · FY2020 · DK
The effects of orange juice compared with sugar-sweetened beverage on risk factors and metabolic processes associated with the development of cardiovascular disease and type 2 diabetes
$741,113Kimber Lee Stanhope · University Of California At Davis · R01 · FY2019 · HL
Paternal Contributions to Metabolic Disease in Offspring: Environment, Epigenetics, and Sperm
$741,030Mary E Patti · Joslin Diabetes Center · R01 · FY2022 · DK
Mediators of fatty liver disease during HIV/SIV and cART treatment
$740,149Donald L Sodora · Seattle Children'S Hospital · R01 · FY2018 · AI
Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction
$739,998John Blangero · University Of Texas Rio Grande Valley · R01 · FY2020 · MD
Atheroprotective Gene Therapy
$739,701David A Dichek · University Of Washington · R01 · FY2019 · HL
Identification of the Exposome in Fatty Liver Disease in Mexican American Families Using Genetic Correction
$739,578John Blangero · University Of Texas Rio Grande Valley · R01 · FY2019 · MD
Genetic determinants of NAFLD severity and progression
$739,560Johanna K Distefano · Translational Genomics Research Inst · R01 · FY2011 · DK
Gut Microbiota-Mediated Inflammatory Interactions Between Alcohol Use Disorders and HIV Infection
$739,324Ali Keshavarzian · Rush University Medical Center · R01 · FY2023 · AA
Research Project 1 - Hepatocellular Genetic Epidemiology of Fatty Liver Disease in Hispanics
$739,200Joanne E Curran · University Of Texas Rio Grande Valley · U54 · FY2023 · HG
Neuroinflammation and Alzheimer's Disease Imaging Biomarkers in Midlife Obesity
$739,042Cyrus A Raji · Washington University · R01 · FY2024 · AG